A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

June 28, 2017

Study Completion Date

June 28, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

CC-220

CC-220 gelatin capsules

Trial Locations (1)

Quintiles Phase One Services, LLC, Overland Park